Godavari Drugs Limited (BSE: 530317)
Health Care · Pharmaceuticals · IN
Rs118.05
-5.70% today · +34.2% 1Y
Godavari Drugs Limited (BSE: 530317) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $12.42M.
Over the last twelve months the share price has gained 34.2%, trading between 69.70 and 135.25.
Tweenvest scores Godavari Drugs Limited across four factors: quality 52/100, value 25/100, growth 0/100. Its strongest factor is quality.
530317 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $12.42M
- Revenue (TTM)
- $11.73M
- P/E
- 23.47
- EPS
- 5.03
- Dividend yield
- —
- Beta (5Y)
- 0.45
- 52-week high
- Rs135.25
- 52-week low
- Rs69.70
- Avg volume (3M)
- —
- Shares outstanding
- 10.13M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| FLUENT Corp.CNSX: FNT.U | $12.76M | $0.02 | -20.00% |
| Liven Pharma LimitedKASE: LIVEN | $12.71M | PKRs31.14 | -1.14% |
| Light AI Inc.DB: 0HC | $12.47M | €0.09 | +12.21% |
| Biogened S.A.WSE: BGD | $12.44M | zł18.90 | -4.06% |
| Aspire-Lakewood Holdings, Inc.NasdaqCM: ASBP | $12.31M | $8.30 | -5.47% |
| ChoA Pharmaceutical Co., LTD.KOSDAQ: A034940 | $12.21M | ₩2,655.00 | -0.56% |
| IDT Australia LimitedASX: IDT | $12.18M | AU$0.04 | -8.89% |
| Rize Oncology Inc.OTCPK: RZON.F | $12.12M | $— | — |
Figures last refreshed Oct 4, 2026.